1. Home
  2. AMCI vs INO Comparison

AMCI vs INO Comparison

Compare AMCI & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Robotics Corporation Common Stock

AMCI

AMC Robotics Corporation Common Stock

HOLD

Current Price

$4.74

Market Cap

110.5M

Sector

Finance

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.08

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCI
INO
Founded
2021
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.5M
100.4M
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
AMCI
INO
Price
$4.74
$1.08
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
151.1K
4.7M
Earning Date
04-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.18
EPS
0.01
N/A
Revenue
$5,980,847.00
$42,220,086.00
Revenue This Year
N/A
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
$481.00
N/A
Revenue Growth
N/A
19.37
52 Week Low
$3.60
$0.56
52 Week High
$15.75
$2.86

Technical Indicators

Market Signals
Indicator
AMCI
INO
Relative Strength Index (RSI) 49.03 61.32
Support Level $4.09 $1.03
Resistance Level $5.81 $1.24
Average True Range (ATR) 0.51 0.08
MACD -0.00 0.03
Stochastic Oscillator 32.58 95.25

Price Performance

Historical Comparison
AMCI
INO

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: